cytosine has been researched along with Adenovirus Infections in 54 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Eight patients were enrolled on a dosage schedule of 1 mg/kg 3 times weekly." | 2.70 | Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. ( Hoffman, JA; Kapoor, N; Ross, LA; Shah, AJ, 2001) |
| " Brincidofovir (BCV) is a lipid formulation of CDV, which has an improved oral bioavailability and favorable toxicity profile compared with CDV." | 2.58 | Adenovirus infection in pediatric transplant recipients: are effective antiviral agents coming our way? ( Green, M; Lopez, SMC; Michaels, MG, 2018) |
| "Adenovirus infections are more common in young children, owing to lack of humoral immunity." | 2.47 | Adenovirus. ( Echavarria, M; Fishbein, M; Lynch, JP, 2011) |
| "Adenovirus infections are increasing as causes of morbidity and mortality in severely immunocompromised patients." | 2.42 | Treatment of adenovirus infections in the immunocompromised host. ( Ljungman, P, 2004) |
| "However, adenovirus infections of immunocompromised patients often develop into life-threatening multi-organ disease." | 1.46 | Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds. ( Spencer, JF; Tollefson, AE; Toth, K; Wold, WSM; Ying, B, 2017) |
| "Patients with gross haematuria and confirmed BK or adenovirus viruria following allo-HSCT were prospectively enrolled in an open-label pharmacokinetic study (ClinicalTrials." | 1.43 | Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients. ( Aitken, SL; Chemaly, RF; Ghantoji, SS; Jones, RB; Kontoyiannis, DP; Tam, VH; Zhou, J, 2016) |
| "To model adenovirus infections in immunocompromised humans, we examined ganciclovir's efficacy in immunosuppressed Syrian hamsters intravenously infected with type 5 human adenovirus (Ad5)." | 1.40 | Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters. ( Balakrishnan, L; Buller, RM; Capella, C; Dewhurst, S; Spencer, JF; Tollefson, AE; Toth, K; Wold, WS; Ying, B, 2014) |
| " No serious adverse events were attributed to CMX001 during therapy." | 1.38 | Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. ( Anderson, M; Florescu, DF; Graham, ML; Guzman-Cottrill, JA; Johnston, C; Kurtzberg, J; Lanier, R; Lewinsohn, DA; Mommeja-Marin, H; Neely, MN; Painter, W; Papanicolaou, G; Pergam, SA; Qiu, F; Rigdon, J; Sande, J; van der Horst, C; Way, S, 2012) |
| "With regard to cancer treatment, replication competent oncolytic adenoviruses have been safe in humans, although their efficacy has been variable." | 1.36 | Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir. ( Bauerschmitz, GJ; Cerullo, V; Diaconu, I; Escutenaire, S; Hemminki, A; Hernandez-Alcoceba, R; Kanerva, A; Pesonen, S, 2010) |
| "Severe adenovirus infections in transplant recipients undergoing immunosuppressive therapy are of increasing concern." | 1.35 | Recovery of humoral immunity is critical for successful antiviral therapy in disseminated mouse adenovirus type 1 infection. ( De Clercq, E; Geboes, L; Kelchtermans, H; Lenaerts, L; Matthys, P; Naesens, L; Verbeken, E, 2008) |
| " Treatment with a modified dosing regimen of cidofovir was well-tolerated and high-risk ADV infections resolved in all patients." | 1.35 | High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. ( Anderson, EJ; Guzman-Cottrill, JA; Katz, BZ; Kletzel, M; Sullivan, C; Thormann, K; Zheng, X, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.85) | 18.7374 |
| 1990's | 5 (9.26) | 18.2507 |
| 2000's | 20 (37.04) | 29.6817 |
| 2010's | 25 (46.30) | 24.3611 |
| 2020's | 3 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Perruccio, K | 1 |
| Menconi, M | 1 |
| Galaverna, F | 1 |
| Pagliara, D | 1 |
| Carraro, F | 1 |
| Fagioli, F | 1 |
| Calore, E | 1 |
| Biffi, A | 1 |
| Baretta, V | 1 |
| Massei, MS | 1 |
| Capolsini, I | 1 |
| Faraci, M | 1 |
| Verna, M | 1 |
| Soncini, E | 1 |
| Caniglia, M | 1 |
| Locatelli, F | 1 |
| Cesaro, S | 1 |
| Hanaoka, N | 1 |
| Hazama, M | 1 |
| Fukushima, K | 1 |
| Fujimoto, T | 1 |
| Romanowski, EG | 6 |
| Yates, KA | 5 |
| Gordon, YJ | 7 |
| Toth, K | 6 |
| Spencer, JF | 5 |
| Ying, B | 4 |
| Tollefson, AE | 4 |
| Wold, WSM | 2 |
| Ramsay, ID | 1 |
| Attwood, C | 1 |
| Irish, D | 1 |
| Griffiths, PD | 1 |
| Kyriakou, C | 1 |
| Lowe, DM | 1 |
| Hibbert, KA | 1 |
| Shepard, JO | 1 |
| Lane, RJ | 1 |
| Azar, MM | 1 |
| Sulejmani, N | 1 |
| Nagai, S | 1 |
| Safwan, M | 1 |
| Rizzari, MD | 1 |
| Raoufi, M | 1 |
| Abouljoud, MS | 1 |
| Ramesh, M | 1 |
| Averbuch, D | 1 |
| Safadi, R | 1 |
| Dar, D | 1 |
| Wolf, D | 1 |
| Cherniak, M | 1 |
| Sorek, R | 1 |
| Amit, S | 1 |
| Lopez, SMC | 1 |
| Michaels, MG | 1 |
| Green, M | 1 |
| Detweiler, CJ | 1 |
| Mueller, SB | 1 |
| Sung, AD | 1 |
| Saullo, JL | 1 |
| Prasad, VK | 1 |
| Cardona, DM | 1 |
| Awosika, OO | 1 |
| Lyons, JL | 1 |
| Ciarlini, P | 1 |
| Phillips, RE | 1 |
| Alfson, ED | 1 |
| Johnson, EL | 1 |
| Koo, S | 1 |
| Marty, F | 1 |
| Drew, C | 1 |
| Zaki, S | 1 |
| Folkerth, RD | 1 |
| Klein, JP | 1 |
| Ronchi, A | 1 |
| Doern, C | 1 |
| Brock, E | 1 |
| Pugni, L | 1 |
| Sánchez, PJ | 1 |
| Balakrishnan, L | 1 |
| Dewhurst, S | 1 |
| Capella, C | 1 |
| Buller, RM | 3 |
| Wold, WS | 4 |
| Swartling, L | 1 |
| Allard, A | 1 |
| Törlen, J | 1 |
| Ljungman, P | 3 |
| Mattsson, J | 1 |
| Sparrelid, E | 1 |
| Aitken, SL | 1 |
| Zhou, J | 1 |
| Ghantoji, SS | 1 |
| Kontoyiannis, DP | 1 |
| Jones, RB | 1 |
| Tam, VH | 1 |
| Chemaly, RF | 1 |
| Lynch, JP | 2 |
| Kajon, AE | 1 |
| Ison, MG | 1 |
| Hayden, RT | 1 |
| Darr, S | 1 |
| Madisch, I | 1 |
| Heim, A | 2 |
| Inoue, H | 1 |
| Sonoda, KH | 1 |
| Ishikawa, M | 1 |
| Kadonosono, K | 1 |
| Uchio, E | 1 |
| Bauzon, M | 1 |
| Jin, F | 1 |
| Kretschmer, P | 1 |
| Hermiston, T | 1 |
| Williams, KM | 1 |
| Agwu, AL | 1 |
| Dabb, AA | 1 |
| Higman, MA | 1 |
| Loeb, DM | 1 |
| Valsamakis, A | 1 |
| Chen, AR | 1 |
| Patel, S | 1 |
| Slatter, M | 1 |
| Valappil, M | 1 |
| Waugh, S | 1 |
| Diaconu, I | 1 |
| Cerullo, V | 1 |
| Escutenaire, S | 1 |
| Kanerva, A | 1 |
| Bauerschmitz, GJ | 1 |
| Hernandez-Alcoceba, R | 1 |
| Pesonen, S | 1 |
| Hemminki, A | 1 |
| Omar, H | 1 |
| Yun, Z | 1 |
| Lewensohn-Fuchs, I | 1 |
| Pérez-Bercoff, L | 1 |
| Orvell, C | 1 |
| Engström, L | 1 |
| Vuong, GK | 1 |
| Clement, C | 1 |
| Capriotti, JA | 1 |
| Kumar, M | 1 |
| Hobden, JA | 1 |
| Foster, TP | 1 |
| Bhattacharjee, PS | 1 |
| Thompson, HW | 1 |
| Mahmud, R | 1 |
| Liang, B | 1 |
| Hill, JM | 1 |
| Keohane, C | 1 |
| Bacon, CL | 1 |
| Moran, B | 1 |
| Irvine, AD | 1 |
| Smith, OP | 1 |
| Fishbein, M | 1 |
| Echavarria, M | 1 |
| Florescu, DF | 1 |
| Pergam, SA | 1 |
| Neely, MN | 1 |
| Qiu, F | 1 |
| Johnston, C | 1 |
| Way, S | 1 |
| Sande, J | 1 |
| Lewinsohn, DA | 1 |
| Guzman-Cottrill, JA | 2 |
| Graham, ML | 1 |
| Papanicolaou, G | 1 |
| Kurtzberg, J | 1 |
| Rigdon, J | 1 |
| Painter, W | 1 |
| Mommeja-Marin, H | 1 |
| Lanier, R | 1 |
| Anderson, M | 1 |
| van der Horst, C | 1 |
| Keddis, M | 1 |
| Leung, N | 1 |
| Herrmann, S | 1 |
| El-Zoghby, Z | 1 |
| Sethi, S | 1 |
| Carter, BA | 1 |
| Karpen, SJ | 1 |
| Quiros-Tejeira, RE | 1 |
| Chang, IF | 1 |
| Clark, BS | 1 |
| Demmler, GJ | 1 |
| Heslop, HE | 1 |
| Scott, JD | 1 |
| Seu, P | 1 |
| Goss, JA | 1 |
| FURUSAWA, E | 1 |
| FURUSAWA, S | 1 |
| CUTTING, W | 1 |
| Hatakeyama, N | 1 |
| Suzuki, N | 1 |
| Kudoh, T | 1 |
| Hori, T | 1 |
| Mizue, N | 1 |
| Tsutsumi, H | 1 |
| Kaneko, H | 1 |
| Mori, S | 1 |
| Suzuki, O | 1 |
| Iida, T | 1 |
| Shigeta, S | 1 |
| Abe, M | 1 |
| Ohno, S | 1 |
| Aoki, K | 2 |
| Suzutani, T | 1 |
| Nagafuji, K | 1 |
| Henzan, H | 1 |
| Kato, K | 1 |
| Miyamoto, T | 1 |
| Eto, T | 1 |
| Nagatoshi, Y | 1 |
| Ohba, T | 1 |
| Obama, K | 1 |
| Gondo, H | 1 |
| Harada, M | 1 |
| De Clercq, E | 4 |
| Andrei, G | 1 |
| Balzarini, J | 1 |
| Leyssen, P | 1 |
| Naesens, L | 2 |
| Neyts, J | 2 |
| Pannecouque, C | 1 |
| Snoeck, R | 1 |
| Ying, C | 1 |
| Hocková, D | 1 |
| Holý, A | 1 |
| Teuchner, B | 1 |
| Nagl, M | 1 |
| Irschick, EU | 1 |
| Keswani, M | 1 |
| Moudgil, A | 1 |
| Lenaerts, L | 1 |
| Kelchtermans, H | 1 |
| Geboes, L | 1 |
| Matthys, P | 1 |
| Verbeken, E | 1 |
| Anderson, EJ | 1 |
| Kletzel, M | 1 |
| Thormann, K | 1 |
| Sullivan, C | 1 |
| Zheng, X | 1 |
| Katz, BZ | 1 |
| Mattner, F | 1 |
| Sykora, KW | 1 |
| Meissner, B | 1 |
| Dhar, D | 1 |
| Sagartz, JE | 1 |
| Painter, GR | 1 |
| Araullo-Cruz, T | 3 |
| de Oliveira, CB | 1 |
| Stevenson, D | 1 |
| LaBree, L | 1 |
| McDonnell, PJ | 1 |
| Trousdale, MD | 1 |
| De Hauwere, B | 1 |
| Lutz, A | 1 |
| Maudgal, PC | 1 |
| Hedderwick, SA | 1 |
| Greenson, JK | 1 |
| McGaughy, VR | 1 |
| Clark, NM | 1 |
| Kinchington, PR | 1 |
| Hoffman, JA | 1 |
| Shah, AJ | 1 |
| Ross, LA | 1 |
| Kapoor, N | 1 |
| Romanowski, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intravesical Cidofovir Instillation in HSCT Recipients With Hemorrhagic Cystitis: A Single Dose Pharmacokinetic Study[NCT01816646] | Phase 1 | 6 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for cytosine and Adenovirus Infections
| Article | Year |
|---|---|
Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - Case series and 10 year experience of management in an adult transplant cohort.
Topics: Adenoviridae Infections; Adult; Antiviral Agents; Cohort Studies; Cytosine; Female; Hematopoietic St | 2017 |
Adenovirus infection in pediatric transplant recipients: are effective antiviral agents coming our way?
Topics: Adenoviridae Infections; Antiviral Agents; Child; Cidofovir; Cytosine; Hematopoietic Stem Cell Trans | 2018 |
Neonatal adenoviral infection: a seventeen year experience and review of the literature.
Topics: Adenoviridae; Adenoviridae Infections; Age Factors; Antiviral Agents; Body Temperature; Cidofovir; C | 2014 |
Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention.
Topics: Adenoviridae; Adenoviridae Infections; Adenovirus Infections, Human; Adult; Antiviral Agents; Child; | 2016 |
Adenovirus.
Topics: Adenoviridae Infections; Antiviral Agents; Cidofovir; Cytosine; Diagnostic Tests, Routine; Disease S | 2016 |
Adenovirus.
Topics: Adenoviridae; Adenoviridae Infections; Adult; Age Factors; Antiviral Agents; Child; Cidofovir; Cytos | 2011 |
Treatment of adenovirus infections in the immunocompromised host.
Topics: Adenoviridae Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytosine; Dose-Respo | 2004 |
2 trials available for cytosine and Adenovirus Infections
| Article | Year |
|---|---|
Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients.
Topics: Adenoviridae; Adenoviridae Infections; Adolescent; Adult; Antiviral Agents; Child; Cidofovir; Cystit | 2004 |
Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation.
Topics: Adenoviridae Infections; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cy | 2001 |
45 other studies available for cytosine and Adenovirus Infections
| Article | Year |
|---|---|
Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses.
Topics: Adenoviridae Infections; Antiviral Agents; Cytosine; Hematopoietic Stem Cell Transplantation; Humans | 2021 |
Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir.
Topics: Adenoviridae Infections; Adenovirus Infections, Human; Cystitis; Cytosine; Humans; Immunocompromised | 2022 |
Cyclopentenylcytosine (CPE-C): In Vitro and In Vivo Evaluation as an Antiviral against Adenoviral Ocular Infections.
Topics: Adenoviridae; Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cytosine; Eye | 2023 |
HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.
Topics: A549 Cells; Adenoviridae Infections; Adenovirus Infections, Human; Adenoviruses, Human; Animals; Ant | 2017 |
Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cytosine; Disease Models, A | 2017 |
Case 1-2018. A 39-Year-Old Woman with Rapidly Progressive Respiratory Failure.
Topics: Adenoviridae; Adenoviridae Infections; Adult; Antiviral Agents; Cidofovir; Cytosine; Diagnosis, Diff | 2018 |
Brincidofovir as Salvage Therapy for Adenovirus Disease in Intestinal Transplant Recipients.
Topics: Adenoviridae Infections; Adult; Antiviral Agents; Cytosine; Female; Humans; Immunocompromised Host; | 2018 |
Successful Brincidofovir Treatment of Metagenomics-detected Adenovirus Infection in a Severely Ill Signal Transducer and Activator of Transcription-1-deficient Patient.
Topics: Adenoviridae Infections; Antiviral Agents; Cytosine; Humans; Immunocompromised Host; Liver; Male; Me | 2019 |
Brincidofovir (CMX001) Toxicity Associated With Epithelial Apoptosis and Crypt Drop Out in a Hematopoietic Cell Transplant Patient: Challenges in Distinguishing Drug Toxicity From GVHD.
Topics: Adenoviridae; Adenoviridae Infections; Autografts; Child, Preschool; Colon; Cytosine; Graft vs Host | 2018 |
Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipient.
Topics: Adenoviridae Infections; Antiviral Agents; Cidofovir; Cord Blood Stem Cell Transplantation; Cytosine | 2013 |
Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Body Weight; Cell Line, Tum | 2014 |
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Alanine Transaminase; Animals; Body Weight; Cell Line; | 2014 |
Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients.
Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Cidofovir; Cytosine; Disease Outbreaks; DNA | 2015 |
New drug on the horizon for treating adenovirus.
Topics: Adenoviridae Infections; Adenoviruses, Human; Adoptive Transfer; Animals; Antiviral Agents; Cidofovi | 2015 |
Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.
Topics: Adenoviridae Infections; Administration, Intravesical; Adolescent; Aged; Antiviral Agents; Cidofovir | 2016 |
Antiviral activity of cidofovir and ribavirin against the new human adenovirus subtype 14a that is associated with severe pneumonia.
Topics: Adenoviridae Infections; Adenoviruses, Human; Antiviral Agents; Cidofovir; Cytosine; Humans; Inhibit | 2008 |
Clinical evaluation of local ocular toxicity in candidate anti-adenoviral agents in vivo.
Topics: Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Conjunctiva; Conjunctivitis, Viral; C | 2009 |
In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer.
Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Cell Survival; Cells, Cultured; Cidofovir; | 2009 |
The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections.
Topics: Adenoviridae Infections; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Ci | 2009 |
A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infection.
Topics: Adenoviridae Infections; Algorithms; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Pr | 2009 |
Persistent adenoviraemia in an infant following haematopoietic stem cell transplantation.
Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Cidofovir; Cytosine; Feces; Female; Hematop | 2010 |
Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Biological Transport; Cell Death; Cell Line; | 2010 |
Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia.
Topics: Adenoviridae Infections; Adult; Antiviral Agents; Asymptomatic Infections; Child; Child, Preschool; | 2010 |
Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Anti-Infective Agents, Local; Cidofovir; Conjunctiva | 2011 |
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by cidofovir.
Topics: Adenoviridae Infections; Cidofovir; Cytosine; Dermatitis, Exfoliative; Drug Eruptions; Eosinophilia; | 2011 |
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.
Topics: Adenoviridae; Adenoviridae Infections; Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Pres | 2012 |
Adenovirus-induced interstitial nephritis following umbilical cord blood transplant for chronic lymphocytic leukemia.
Topics: Acute Kidney Injury; Adenoviridae Infections; Adult; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient.
Topics: Adenoviridae; Adenoviridae Infections; Alanine Transaminase; Antiviral Agents; Blood; Child; Cidofov | 2002 |
FURTHER STUDIES OF DRUG COMBINATIONS FOR COMPLETE CURE OF DNA VIRUS INFECTION IN CULTURED CELLS.
Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Bromodeoxyuridine; Cells, Cultured; Cytosin | 1965 |
Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant.
Topics: Acute Kidney Injury; Adenoviridae; Adenoviridae Infections; Bone Marrow Transplantation; Cidofovir; | 2003 |
The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.
Topics: Adenoviridae Infections; Adenoviruses, Human; Administration, Topical; Animals; Antigens, Viral; Ant | 2004 |
Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cidofo | 2005 |
N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Cornea; Cytosine; Disea | 2006 |
Adenovirus-associated hemorrhagic cystitis in a pediatric renal transplant recipient.
Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Child, Preschool; Cidofovir; Cystitis; Cyto | 2007 |
Recovery of humoral immunity is critical for successful antiviral therapy in disseminated mouse adenovirus type 1 infection.
Topics: 3T3 Cells; Adenoviridae; Adenoviridae Infections; Animals; Antibodies, Viral; Antiviral Agents; Cell | 2008 |
High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy.
Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Case-Control Studies; Child; Cidofovir; Cyt | 2008 |
An adenovirus type F41 outbreak in a pediatric bone marrow transplant unit: analysis of clinical impact and preventive strategies.
Topics: Adenoviridae; Adenoviridae Infections; Adolescent; Antiviral Agents; Blood; Bone Marrow Transplantat | 2008 |
Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Antiviral Agents; Cricetinae; Cytosine; Disease Mode | 2008 |
Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Cytosine; Eye In | 1994 |
Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antibodies, Viral; Cidofovir; Cytosine; Disea | 1996 |
An ocular model of Adenovirus type 5 infection in the rabbit.
Topics: Adenine; Adenoviridae; Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Cytosine; Dise | 1995 |
Adenovirus cholecystitis in a patient with AIDS.
Topics: Adenoviridae Infections; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cholecystit | 1998 |
The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Conjunctivitis, | 2001 |
Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Conjunctivitis, | 2001 |
Pretreatment with topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Colony Count, Microbial | 1992 |